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1. INTRODUCTION 
The gonadotropin releasing hormone (GnRH) 
acts to release bovine luteinizing hormone (LH) [I] 
as well as follicle-stimulating hormone (FSH) [2] in 
vivo and stimulates the release of LH from bovine 
anterior pituitary tissue slices during superfusion in 
vitro in a dose-dependent manner [ 11. Fully biolog- 
ically active ‘251-labeled GnRH binds to isolated 
anterior pituitary cells in a dose-dependent and 
saturable manner and the concentration depen- 
dence curve (physiological concentrations of 
GnRH) exhibits positive cooperativity [3,4]. Simi- 
larly, GnRH binding in isolated anterior pituitary 
plasma membranes, solubilized plasma membranes 
and purified GnRH receptor protein (GnRH.RP) is 
to multiple binding sites [5]. GnRH.RP purified to 
homogeneity aggregates in solution upon binding 
of GnRH present in physiological concentrations 
I51. 
The concentration-dependence binding curves of 
labeled GnRH to isolated anterior pituitary cells of 
different origin suggested involvement of sex ster- 
oids [3,4]. The apparent effect of a predominantly 
estrogenic environment was inducible by the pre- 
treatment of steer anterior pituitary plasma mem- 
branes in vitro with physiological concentrations of 
estradiol 17-p [3,4]. Here, the modulation of GnRH 
binding by estradiol 17-P at the level of GnRH.RP 
is investigated since steroids were implicated in 
normal LH response to GnRH in the bovine [ 1,6] as 
well as other species [7,8] and in the feedback con- 
trol of preovulatory LH surge, in general. 
2. MATERIALS AND METHODS 
Details of the methodology used here may be 
found in [4,5,9]. Briefly, the GnRH receptor protein 
was coupled to a nylon fiber through an acyl-azide 
intermediate at a rate of 23 fmol/fiber. Binding 
kinetics were then studied with labeled GnRH in 
solution. The affinity fiber was first pretreated for 
10 min in buffer (Tris-HCl, 0.1 M, pH 9.0) then 
incubated for 30 min with 1251-GnRH. Washing, in 
excess of plain buffer, was for 3 min. In experiments 
with estradiol pretreatment, the fibers were incu- 
bated with the specified concentration of steroid in 
buffer for 10 min, then washed slightly 
incubation with ‘*’ I-GnRH (7 X IO- ’ r? 
rior to the 
M). 
Separation of bound and free GnRH was by re- 
moval of the solid phase from the solution and 
thoroughly washing it in excess buffer. The solid 
phase was then counted in the y-counter for retain- 
ed ‘251-radioactivity. For all assays, non-specific 
(non-saturable) binding was determined by incu- 
bating the test material in the presence of 10 ~ ’ M 
GnRH. This was subtracted from total binding and, 
unless otherwise stated, the results represent satur- 
able or specific binding. Non-specific absorption of 
labeled protein was also subtracted. 
3. RESULTS 
The concentration-dependence binding curve of 
‘251-GnRH to purified GnRH receptor protein is 
shown in fig. 1. This binding had the characteristics 
described earlier but 3 3 bindin 
within 7 x lo-” -- % 
sites participating 
7 x 10 -’ M GnRH. Half- 
maximum binding occurred at (1.7 ? 0.2) X 
10-t’ M. (3.0 ? 0.3) x lo-” M and (5.9 + 0.3) 
x lo- ‘” M GnRH, respectively. The binding curve 
resembles that of the intact anterior pituitary 
membranes and solubilized anterior pituitary 
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Fig. 1. Concentration dependence of specific tZ51-GnRH 
binding to purified GnRH receptor protein. The values 
represent mean f SE of 6 parallel measurements. The 
result is typical of 6 similar expt obtained with different 
batches of the receptor protein. 
membranes. A detailed description of similar pre- 
parations appeared in [5,7]. 
The effect of estradiol 17-p, which is the main 
estrogen in cattle, has been investigated at physio- 
logical levels (0.3-40 pg/ml). 
Estradiol 17-p in the buffer, prior to the exposure 
of immobilized receptor protein to its hormone, 
decreased subsequent binding of labeled GnRH to 
the immobilized receptor protein (fig.2). This de- 
crease was dose dependent but plateaus were ob- 
served at 0.6-2.5 pg/ml and lo-40 pg/ml estradiol. 
This phenomenon was observed in 6 expt run with 4 
batches of purified GnRH receptor protein. Statis- 
tical analysis by Student’s t-test was done for the 
sextuplets for each of 0.6, 1.2 and 2.5 pg estra- 
dial/ml as one group and 10, 20 and 40 pg estra- 
dial/ml as the other group, respectively. The differ- 
ence between the group means was highly signifi- 
cant (P < 0.001) while the difference within the 
means was not (P > 0.5). This suggests hindrance of 
some binding sites for ‘251-GnRH depending on the 
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Fig.2. Specific binding of t2%GnRH to its receptor pro- 
tein pretreated with specified concentrations of estradiol 
17-p. The dots represent means of: SE of 6 parallel mea- 
surements. The result is typical of 6 similar expt obtained 
with different batches of the receptor protein. 
estradiol 17-p level in the preincubation medium. 
Whether there is an additional plateau at < 0.3 pg 
estradiol/ml is under investigation and of theoreti- 
cal value only. The physiological level is rarely < 1 
pg/ml; it is on av 5.1 pg/ml on day 15 of the cycle; 
10.8 pg/ml on the day prior to ovulation; and 
higher when stimulated (61. 
4. DISCUSSION 
The evidence that estradiol 17-p at physiological 
levels modulates GnRH binding to immobilized 
purified GnRH receptor protein is the first demon- 
stration that its effect on isolated anterior pituitary 
plasma membrane, and possibly on the secretion of 
LH from anterior pituitary tissue in vitro [4] and in 
vivo [6], is mediated directly by the GnRH receptor. 
Similarly, these findings suggest that the concen- 
tration of GnRH need not vary greatly to induce the 
27 
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ovulatory stimulus [6]. Experiments designed to 
provide details of molecular events underlying the 
feedback mechanism involved in the release of 
gonadotropins at the pituitary level are underway. 
Since GnRH binding under these conditions is 
mediated by a single molecular entity (receptor 
protein) the different capacity of ‘251-GnRH which 
is estradiol 17-p concentration-dependent indicates 
the effect of estradiol 17-p on the hindrance of some 
binding sites, depending on the estradiol level. 
Considering that only one concentration of 
‘251-GnRH was used (lo- 9 M) here, the receptor 
protein, even though immobilized, may have bound 
estradiol 17-p to the same or similar sites, which are 
responsible for the stepwise or sigmoid concentra- 
tion-dependence binding curves of a fully bio- 
logically active 12’I-GnRH [3-5,9]. Thus these 
data support the structural model of the gonado- 
tropin hormone receptor. 
Whether the effect of estradiol 17-p described 
here is of any importance in explaining the contra- 
ceptive effect of ‘the pill’ is of interest. Under con- 
tinuously elevated estradiol 17-p concentration the 
binding of the gonadotropin releasing hormone is 
low and thus the effect of the releasing hormone on 
luteinizing hormone release could be abolished, at 
least in part. Since the estradiol 17-p levels used in 
these experiments are physiological, the question 
could be of much clinical interest. 
These observations for gonadotropin releasing 
hormone may be relevant for the definition of the 
biological function of the receptor in general and 
warn that the concentrations of the individual pep- 
tide hormones might not be physiologically as rele- 
vant as earlier suspected. For example, under 
varying concentrations of steroids extracellularly 
the receptor may be modified and the physiological 
importance of hormone concentration measure- 
ment will vary accordingly. Receptor protein bind- 
ing as described here may be a useful parameter of 
biological function of the hormone (in this case the 
gonadotropin releasing hormone) because it esti- 
mates the extent of the hormone-receptor inter- 
action and, therefore, true biological outcome, 
largely independently of widely fluctuating 
(precisely measured) hormone concentrations. 
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